Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (246)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Revumenib	EZH2 / Menin Inhibitor	Hematologic
Molecule Revumenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Ziftomenib	EZH2 / Menin Inhibitor	Hematologic
Molecule Ziftomenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Bleximenib	EZH2 / Menin Inhibitor	Hematologic
Molecule Bleximenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Enzomenib	EZH2 / Menin Inhibitor	Hematologic
Molecule Enzomenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Bortezomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Bortezomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Carfilzomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Carfilzomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Ixazomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Ixazomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Marizomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Marizomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Oprozomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Oprozomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Delanzomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Delanzomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Vorinostat	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Vorinostat Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Romidepsin	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Romidepsin Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor

Revumenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Ziftomenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Bleximenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Enzomenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Bortezomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Carfilzomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Ixazomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Marizomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Oprozomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Delanzomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Vorinostat Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Romidepsin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor

‹ 1 … 14 15 16 17 18 … 21 ›

Product Range

Company

Global Network

Products

Revumenib

Ziftomenib

Bleximenib

Enzomenib

Bortezomib

Carfilzomib

Ixazomib

Marizomib

Oprozomib

Delanzomib

Vorinostat

Romidepsin